1. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation
- Author
-
Spruit, M.A., Singh, S.J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A.E., Lareau, S.C., Man, W.D., Pitta, F., Sewell, L., Raskin, J., Bourbeau, J., Crouch, R., Franssen, F.M., Casaburi, R., Vercoulen, J.H.M.M., Vogiatzis, I., Gosselink, R., Clini, E.M., Effing, T.W., Maltais, F., Palen, J.A.M. van der, Troosters, T., Janssen, D.J., Collins, E., Garcia-Aymerich, J., Brooks, D., Fahy, B.F., Puhan, M.A., Hoogendoorn, M., Garrod, R., Schols, A.M.W.J., Carlin, B., Benzo, R., Meek, P., Morgan, M., Molken, M.P. Rutten-van, Ries, A.L., Make, B., Goldstein, R.S., Dowson, C.A., Brozek, J.L., Donner, C.F., Wouters, E.F., Rehabilitation, A.E.T.F.o.P., RS: CAPHRI School for Public Health and Primary Care, RS: NUTRIM - R3 - Chronic inflammatory disease and wasting, Family Medicine, Pulmonologie, University of Zurich, Faculty of Behavioural, Management and Social Sciences, and Health Economics (HE)
- Subjects
Pulmonary and Respiratory Medicine ,Lung Diseases ,medicine.medical_specialty ,INTENSIVE-CARE-UNIT ,Exacerbation ,medicine.medical_treatment ,MEDLINE ,METIS-300801 ,610 Medicine & health ,AIR-FLOW LIMITATION ,Motor Activity ,Critical Care and Intensive Care Medicine ,outcomes ,Pulmonary Disease, Chronic Obstructive ,Quality of life (healthcare) ,exacerbation ,QUALITY-OF-LIFE ,6-MINUTE WALK DISTANCE ,MINIMAL IMPORTANT DIFFERENCE ,medicine ,Humans ,COPD ,Pulmonary rehabilitation ,FUNCTIONAL EXERCISE CAPACITY ,INSPIRATORY MUSCLE STRENGTH ,Intensive care medicine ,Lung ,NEUROMUSCULAR ELECTRICAL-STIMULATION ,Chronic care ,Rehabilitation ,business.industry ,behavior ,IR-88633 ,Respiratory disease ,Psychological determinants of chronic illness [NCEBP 8] ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,RANDOMIZED CONTROLLED-TRIAL ,medicine.disease ,pulmonary rehabilitation ,Bronchodilator Agents ,Exercise Therapy ,Pathogenesis and modulation of inflammation [N4i 1] ,2740 Pulmonary and Respiratory Medicine ,Physical therapy ,business ,2706 Critical Care and Intensive Care Medicine ,CRITICALLY-ILL PATIENTS - Abstract
Background: Pulmonary rehabilitation is recognized as a core component of the management of individuals with chronic respiratory disease. Since the 2006 American Thoracic Society (ATS)/European Respiratory Society (ERS) Statement on Pulmonary Rehabilitation, there has been considerable growth in our knowledge of its efficacy and scope. Purpose: The purpose of this Statement is to update the 2006 document, including a new definition of pulmonary rehabilitation and highlighting key concepts and major advances in the field. Methods: A multidisciplinary committee of experts representing the ATS Pulmonary Rehabilitation Assembly and the ERS Scientific Group 01.02, “Rehabilitation and Chronic Care,” determined the overall scope of this update through group consensus. Focused literature reviews in key topic areas were conducted by committee members with relevant clinical and scientific expertise. The final content of this Statement was agreed on by all members. Results: An updated definition of pulmonary rehabilitation is proposed. New data are presented on the science and application of pulmonary rehabilitation, including its effectiveness in acutely ill individuals with chronic obstructive pulmonary disease, and in individuals with other chronic respiratory diseases. The important role of pulmonary rehabilitation in chronic disease management is highlighted. In addition, the role of health behavior change in optimizing and maintaining benefits is discussed. Conclusions: The considerable growth in the science and application of pulmonary rehabilitation since 2006 adds further support for its efficacy in a wide range of individuals with chronic respiratory disease Read More: http://www.atsjournals.org/doi/abs/10.1164/rccm.201309-1634ST
- Published
- 2013